Regulus announces completion of public offering of common stock and underwriters option
Regulus Therapeutics announced completion of its previously announced underwritten public offering of 50,600,000 shares of its common stock, including 6,600,000 shares sold pursuant to the full exercise of an option previously granted to the underwriters. July 25, 2017